The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.

Perspective
Public
The Greek philosopher Heraclitus gets the credit for observing that “the only constant in life is change.” Yet it is something we all know is true because we…
Headline
The National Center for Healthcare Leadership July 14 announced that Michelle Hood, AHA executive vice president and COO, is the recipient of NCHL's 2026 Gail…
Headline
The AHA Board of Trustees Board of Trustees has elected Laura Kaiser, president and CEO of SSM Health, based in St. Louis, Mo., as its chair-…
Headline
The AHA June 30 announced the appointment of Steve Walsh as its next president and chief executive officer. Walsh, who has served as president and CEO of the…
Perspective
Public
Every day, hospitals and health systems are finding new and better ways to care for the people and communities they serve.You can see it in predictive…
Blog
Public
The American Hospital Association Leadership Summit will take place July 12-14 at the Colorado Convention Center in Denver. Renowned speakers from across…